Cardio Diagnostics Holdings, Inc. (CDIO): Utang-utang marang kapitalisasi buku

Tandha merek cardiodiagnosticsinc.com (CDIO)

How can Cardio Diagnostics (CDIO) make cardiac screening mass-market through AI and epigenetics? The total debt-to-market capitalization ratio demonstrates a downward trend, where 0.05 serves as the base parameter value. Stable demand for diagnostics and insurance coverage ensure macro-stability, while the leadership's scientific potential helps optimize expenses amid limited capital for scaling the platform.

CDIO Rasio utang marang nilai buku Cardio Diagnostics Holdings (28.04.2023 - 26.10.2026)
Produk asli Cardio Diagnostics Holdings Inc.

This ratio compares total liabilities to equity to assess the degree of financial leverage. It determines the business's dependence on external financing and the risk of insolvency during market volatility. Monitoring borrowed funds relative to balance sheet capital allows an investor to evaluate the stability of the asset structure. For Cardio Diagnostics (CDIO), this balance is critical when scaling AI solutions. Debt optimization will ensure the secure implementation of personalized genetic tests.

Pesaing Cardio Diagnostics

A - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku questdiagnostics.com DGX|Illumina - Utang-utang marang kapitalisasi buku|EXAS: Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku PerkinElmer|Bio-Rad Corp (BIO) - Rasio utang marang nilai buku|NNNN (Anbio Biotechnology) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku SHC|Rasio utang marang kapitalisasi buku QuidelOrtho Corporation (QDEL)|Rasio utang marang kapitalisasi buku OPKO Health Inc OPK|CDNA: Utang marang nilai buku|Maravai - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku FLGT (Fulgent Genetics, Inc.)|LAB - Utang-utang marang aset resik|Cytek Biosciences - Utang-utang marang kapitalisasi buku|OSUR (OraSure Technologies, Inc.) - Utang-utang marang aset resik|XGN: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik MDxHealth, Inc.|Utang-utang marang kapitalisasi buku LUCD (Lucid Diagnostics Inc.)|Utang marang nilai buku prenetics.com (PRE)|Utang-utang marang kapitalisasi buku IMDX (Insight Molecular Diagnostics Inc)|Trinity Biotech PLC - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku ProPhase (PRPH)|AIMD - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku Co-Diagnostics, Inc.|heartsciences.com (HSCS) - Rasio utang marang nilai buku|BMRA: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik VRAX|Bluejay - Rasio utang marang kapitalisasi buku|Utang-utang marang nilai buku Aspira Women's Health Inc AWH|Utang marang nilai buku Accelerate Diagnostics|Rasio utang marang aset resik centogene.com CNTG|Enzo (ENZ) - Utang-utang marang kapitalisasi buku|FRES - Rasio utang marang nilai buku|gtglabs.com - Utang-utang marang kapitalisasi buku|23andMe Inc (ME) - Utang-utang marang aset resik|PMD (Psychemedics) - Utang-utang marang kapitalisasi buku